Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat.

Saved in:
Bibliographic Details
Title: Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat.
Authors: Meling D; Psychedelic Research and Therapy Development, Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich, University of Zurich, Zurich, Switzerland.; Department of Psychosomatic Medicine and Psychotherapy, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Egger K; Psychedelic Research and Therapy Development, Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, Swiss Federal Institute of Technology Zurich, University of Zurich, Zurich, Switzerland.; Department of Nuclear Medicine, Bern University Hospital, Bern, Switzerland., Aicher HD; Psychedelic Research and Therapy Development, Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, Swiss Federal Institute of Technology Zurich, University of Zurich, Zurich, Switzerland.; Department of Psychology, University of Zurich, Zurich, Switzerland., Jareño Redondo J; Psychedelic Research and Therapy Development, Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich, University of Zurich, Zurich, Switzerland., Mueller J; Psychedelic Research and Therapy Development, Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich, University of Zurich, Zurich, Switzerland., Dornbierer J; Psychedelic Research and Therapy Development, Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, Swiss Federal Institute of Technology Zurich, University of Zurich, Zurich, Switzerland., Temperli E; Psychedelic Research and Therapy Development, Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich, University of Zurich, Zurich, Switzerland., Vasella EA; Psychedelic Research and Therapy Development, Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich, University of Zurich, Zurich, Switzerland., Caflisch L; Psychedelic Research and Therapy Development, Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich, University of Zurich, Zurich, Switzerland.; Department of Psychology, University of Zurich, Zurich, Switzerland., Pfeiffer DJ; Psychedelic Research and Therapy Development, Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich, University of Zurich, Zurich, Switzerland., Schlomberg JT; Psychedelic Research and Therapy Development, Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich, University of Zurich, Zurich, Switzerland.; Department of Psychology, University of Zurich, Zurich, Switzerland.; Digital Society Initiative, University of Zurich, Zurich, Switzerland., Smallridge JW; Psychedelic Research and Therapy Development, Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich, University of Zurich, Zurich, Switzerland., Dornbierer DA; Psychedelic Research and Therapy Development, Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich, University of Zurich, Zurich, Switzerland., Scheidegger M; Psychedelic Research and Therapy Development, Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, Swiss Federal Institute of Technology Zurich, University of Zurich, Zurich, Switzerland.
Source: Journal of psychopharmacology (Oxford, England) [J Psychopharmacol] 2024 Oct; Vol. 38 (10), pp. 897-910. Date of Electronic Publication: 2024 Sep 27.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Sage Publications Country of Publication: United States NLM ID: 8907828 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1461-7285 (Electronic) Linking ISSN: 02698811 NLM ISO Abbreviation: J Psychopharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1461-7285
DOI:10.1177/02698811241282637